Untangling obese asthma: Design of proof-of-concept study of semaglutide in poorly controlled asthma

Advancing our understanding of obesity-associated asthma requires moving beyond body mass index-focused models to fully consider the metabolic complexity of the disease. Integrating detailed metabolic assessments into research and clinical practice will be vital for identifying responsive subpopulations, optimizing treatment strategies, and ultimately improving patient outcomes.